UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A7K5B3Y0 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7K5B619 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K5AKV3 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K5AKY9 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K5AH11 | Voltage-dependent T-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K5AWU5 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7K5AZ14 | ATS1 metalloproteinase (Fragment) |
|
2 | 0 |
|
A0A7K5ART2 | N-acetylgalactosamine-6-sulfatase (Fragment) |
|
1 | 0 |
|
A0A7K5AHD2 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K5BEV5 | Protein adenylyltransferase FICD (Fragment) |
|
1 | 0 |
|
A0A7K5B9J8 | KCNKH protein (Fragment) |
|
1 | 0 |
|
A0A7K5AXH7 | BACE2 secretase (Fragment) |
|
1 | 0 |
|
A0A7K5AXV1 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7K5AKB0 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K5ARA6 | Fibroblast growth factor receptor 1 (Fragment) |
|
8 | 0 |
|
A0A7K5B548 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7K5AR82 | GFRA1 protein (Fragment) |
|
2 | 0 |
|
A0A7K5BDE2 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K5ANE0 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7K5AQX3 | Angiotensin-converting enzyme (Fragment) |
|
2 | 0 |
|
A0A7K5AXI1 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7K5AGC1 | NOGG protein (Fragment) |
|
1 | 0 |
|
A0A7K5ALK5 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
A0A7K5B703 | Potassium channel subfamily K member 1 (Fragment) |
|
1 | 0 |
|
A0A7K5BEW0 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024